Bismuth subnitrate 20% / Iodoform 40% paste impregnated gauze dressing 1.25cm x 200cm

Země: Velká Británie

Jazyk: angličtina

Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivní složka:

Bismuth subnitrate; Iodoform

Dostupné s:

Martindale Pharmaceuticals Ltd

ATC kód:

n/a

INN (Mezinárodní Name):

Bismuth subnitrate; Iodoform

Dávkování:

200mg/1gram ; 400mg/1gram

Léková forma:

Impregnated dressing

Podání:

Cutaneous

Třída:

No Controlled Drug Status

Druh předpisu:

Valid as a prescribable product

Přehled produktů:

BNF: 12020300; GTIN: 5026468000098

Charakteristika produktu

OBJECT 1
BISMUTH SUBNITRATE AND IODOFORM PASTE
IMPREGNATED GAUZE
Summary of Product Characteristics Updated 18-Feb-2015 | Martindale
Pharma
1. Name of the medicinal product
Bismuth Subnitrate and Iodoform Paste Impregnated Gauze.
2. Qualitative and quantitative composition
A lemon yellow paste impregnated gauze with characteristic antiseptic
odour.
The gauze is impregnated with a paste of composition.
Bismuth Subnitrate
BPC 1973
20% w/w.
Iodoform
BPC 1954
40% w/w.
Paraffin Liquid
BP
40% w/w.
3. Pharmaceutical form
A paste impregnated gauze.
4. Clinical particulars
4.1 Therapeutic indications
a) _Post ENT Surgical Procedures_
As an antiseptic gauze used to prevent infection and thus assist
healing following ENT procedures.
It is not recommended that the impregnated gauze be placed into open
wounds.
b) _Acute Epistaxis_
To pack the nasal cavity in order to reduce/stop the flow of blood.
4.2 Posology and method of administration
a) In ENT surgical procedures
Sufficient impregnated gauzes should be packed into the cavity to
protect the operation site from bacterial
challenge. The gauze is left in place until the wound has healed or
graft taken.
It is not recommended that the impregnated gauze be placed into open
wounds.
b) Acute epistaxis
Sufficient impregnated gauze(s) is packed up in the nose to stop the
blood flow. The gauze is removed the
following day or when clinical judgement dictates.
4.3 Contraindications
Known hypersensitivity to Iodoform, iodine and bismuth.
4.4 Special warnings and precautions for use
Use with caution with patients suffering from hyperthyroidism.
4.5 Interaction with other medicinal products and other forms of
interaction
None known.
4.6 Pregnancy and lactation
There is insufficient evidence of safety in pregnancy, as with all
drugs it is not recommended the product
is used in pregnancy.
4.7 Effects on ability to drive and use machines
Not applicable.
4.8 Undesirable effects
Hypersensitivity to iodine can result in an erythematous rash, which
subsides on removal of the gauze.
Although rar